Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
[
Title
]
Type
Year
Filters:
Author
is
Berceanu, Ana
[Clear All Filters]
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
1
Xhaard A
,
Xhaard C
,
Rubio M-T
,
Berceanu A
,
Botella-Garcia C
,
Coman T
,
Tavernier E
,
Labussière-Wallet H
,
Chevallier P
,
Legrand F
, et al.
A 16-month-long experience of COVID-19 in allogeneic haematopoietic stem cell transplantation recipients: An SFGM-TC multicentre cohort study.
Br J Haematol. 2023.
PubMed
Google Scholar
C
Trad R
,
Warda W
,
Alcazer V
,
da Rocha MNeto
,
Berceanu A
,
Nicod C
,
Haderbache R
,
Roussel X
,
Desbrosses Y
,
Daguindau E
, et al.
Chimeric antigen receptor T-cells targeting IL-1RAP: a promising new cellular immunotherapy to treat acute myeloid leukemia.
J Immunother Cancer. 2022;10(7).
PubMed
Google Scholar
Peterlin P
,
Le Bris Y
,
Turlure P
,
Chevallier P
,
Ménard A
,
Gourin M-P
,
Dumas P-Y
,
Thépot S
,
Berceanu A
,
Park S
, et al.
CPX-351 in higher risk myelodysplastic syndrome and chronic myelomonocytic leukaemia: a multicentre, single-arm, phase 2 study.
Lancet Haematol. 2023.
PubMed
Google Scholar
E
Jullien M
,
Orvain C
,
Berceanu A
,
Couturier M-A
,
Guillaume T
,
Peterlin P
,
Garnier A
,
Le Bourgeois A
,
Klemencie M
,
Schmidt A
, et al.
Early Post-Transplant Serum Ferritin Levels Predict Survivals in Recipients of Haploidentical Stem Cell Transplantation Using PTCY as GVHD Prophylaxis.
Transplant Cell Ther. 2021.
PubMed
Google Scholar
Fayard A
,
Daguenet E
,
Blaise D
,
Chevallier P
,
Labussière H
,
Berceanu A
,
Yakoub-Agha I
,
Socié G
,
Charbonnier A
,
Suarez F
, et al.
Evaluation of infectious complications after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide following reduced-intensity and myeloablative conditioning: a study on behalf of the Francophone Society of Stem Cell
. Bone Marrow Transplant. 2019.
PubMed
Google Scholar
G
Chevallier P
,
Berceanu A
,
Peterlin P
,
Garnier A
,
Le Bourgeois A
,
Imbert B-M
,
Daguindau E
,
Mahe B
,
Dubruille V
,
Blin N
, et al.
Grade 2 acute GVHD is a factor of good prognosis in patients receiving peripheral blood stem cells haplo-transplant with post-transplant cyclophosphamide.
Acta Oncol. 2020:1-9.
PubMed
Google Scholar
I
Jullien M
,
Orvain C
,
Berceanu A
,
Couturier M-A
,
Guillaume T
,
Peterlin P
,
Garnier A
,
Le Bourgeois A
,
Klemencie M
,
Schmidt A
, et al.
Impact of allogeneic stem cell transplantation comorbidity indexes after haplotransplant using post-transplant cyclophosphamide.
Cancer Med. 2021.
PubMed
Google Scholar
O
Michel C
,
Robin M
,
Morisset S
,
Blaise D
,
Maertens J
,
Chevalier P
,
Castilla-Llorente C
,
Forcade E
,
Ceballos P
,
Yakoug-Agha I
, et al.
Outcome after allogeneic stem cell transplantation with haploidentical versus HLA-matched donors in patients with higher-risk MDS.
Bone Marrow Transplant. 2023.
PubMed
Google Scholar
R
Rossi M
,
Szepetowski S
,
Yakouben K
,
Paillard C
,
Sirvent A
,
Castelle M
,
Pegon C
,
Piguet C
,
Grain A
,
Angoso M
, et al.
Recent results of hematopoietic stem cell transplantation for thalassemia with busulfan-based conditioning regimen in France: improved thalassemia free survival despite frequent mixed chimerism. A retrospective study from the Francophone Society of Stem C
. Bone Marrow Transplant. 2023.
PubMed
Google Scholar
Caillet A
,
Bellanger A-P
,
Navellou JChristophe
,
Daguindau E
,
Rocchi S
,
Scherer E
,
Berceanu A
,
Millon L
.
Refractory invasive pulmonary aspergillosis due to Aspergillus flavus detected with the combination of two in-house Aspergillus qPCR.
J Mycol Med. 2022;33(1):101350.
PubMed
Google Scholar
S
Gavriilaki E
,
Sakellari I
,
Labopin M
,
Bornhäuser M
,
Hamladji R-M
,
Casper J
,
Edinger M
,
Žák P
,
Yakoub-Agha I
,
Ciceri F
, et al.
Survival advantage of treosulfan plus fludarabine (FT14) compared to busulfan plus fludarabine (FB4) in active acute myeloid leukemia post allogeneic transplantation: an analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute
. Bone Marrow Transplant. 2023.
PubMed
Google Scholar
T
Saraceni F
,
Labopin M
,
Raiola AM
,
Blaise D
,
Reményi P
,
Sorà F
,
Pavlu J
,
Bramanti S
,
Busca A
,
Berceanu A
, et al.
Thiotepa-busulfan-fludarabine Compared to Treosulfan-based Conditioning for Haploidentical Transplant With Posttransplant Cyclophosphamide in Patients With Acute Myeloid Leukemia in Remission: A Study From the Acute Leukemia Working Party of the EBMT.
Hemasphere. 2023;7(10):e952.
PubMed
Google Scholar
Swoboda R
,
Labopin M
,
Giebel S
,
Schroeder T
,
Kröger N
,
Arat M
,
Savani B
,
Spyridonidis A
,
Hamladji R-M
,
Potter V
, et al.
Total body irradiation plus fludarabine versus busulfan plus fludarabine as a myeloablative conditioning for adults with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation. A study on behalf of the Acute Leukemia Working Par
. Bone Marrow Transplant. 2022.
PubMed
Google Scholar